TIM
BMY icon

Titan Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Titan Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
31,955
+1,371
+4% +$78.7K 1.36% 24
2026
Q1 		$1.85M Sell
30,584
-726
-2% -$42.3K 1.64% 25
2025
Q4 		$1.69M Buy
+31,310
New +$1.51M 1.54% 25

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Titan Investment Management's BMY Position: Q2 2026 in Review

Titan Investment Management increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q2 2026, buying an estimated $78.7K and bringing the position to 31,955 shares worth $1.84M. The position accounts for 1.36% of the portfolio, ranked #24.

Titan Investment Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.85M in Q1 2026. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Titan Investment Management held 31,955 shares of Bristol-Myers Squibb worth $1.84M as of Q2 2026.
  • Titan Investment Management bought 1,371 Bristol-Myers Squibb shares in Q2 2026, an estimated $78.7K.
  • Bristol-Myers Squibb made up 1.36% of Titan Investment Management's portfolio in Q2 2026, its #24 holding.
  • Titan Investment Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Titan Investment Management's Bristol-Myers Squibb position peaked at $1.85M in Q1 2026.
  • 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Titan Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.